ID
22437
Description
A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT02013206
Link
https://clinicaltrials.gov/show/NCT02013206
Keywords
Versions (1)
- 6/4/17 6/4/17 -
Uploaded on
June 4, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Non-Small Cell Lung Cancer NCT02013206
Eligibility Non-Small Cell Lung Cancer NCT02013206
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
previous therapy which acts on epidermal growth factor receptor (egfr) axis
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C1443775
Description
brain metastasis
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
any unstable systemic disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0443343
- UMLS CUI [1,2]
- C0442893
Description
unable to take oral medication
Data type
boolean
Alias
- UMLS CUI [1]
- C2222393
Description
ophthalmological abnormality
Data type
boolean
Alias
- UMLS CUI [1]
- C0015397
Similar models
Eligibility Non-Small Cell Lung Cancer NCT02013206
- StudyEvent: Eligibility
C0205179 (UMLS CUI [1,2])
C0449575 (UMLS CUI [1,3])
C1300072 (UMLS CUI [1,4])
C1443775 (UMLS CUI [1,2])
C0442893 (UMLS CUI [1,2])